Growth hormone related with signs of aging

The decreased production of growth hormone is caused by a physiological process known as somatopause, which practically affects the entire body, since it's involved in body composition, metabolism, bone mineral density and cardiovascular function.

According to Adrian Tovar, a specialist of internal medicine and director of the Noor Clinic, it is from the fourth decade of that levels of secreted naturally by the begin to decline, which may manifest in signs of aging, such as narrowing of the spine and lack of dynamism.

While growth hormone determines the height of children, it also intervenes when growth is complete. "It has been documented that, for example, in the case of the heart (which is structurally a muscle), those who have a deficit in growth hormone may have reduced life expectancy by the accelerated loss of muscle mass," referred the specialist.

He added, that it even has an effect on the morale and intellectual status. "Because of all these symptoms the quality of life decreases and adults who are deficient in growth hormone complain about discouragement, tiredness and lack of dynamism. In particular cases, some may experience depression and social isolation," said Tovar, fellow member of the European Society of Endocrinology.

On the metabolic function of the body, the specialist said that studies show that in the first years of life growth hormone is very active; however, when their natural levels drop, the assimilation of proteins, lipids and carbohydrates is affected, and therefore, the levels of cholesterol and triglycerides.

Dr. Tovar said that "by administering recombinant to adults (between 40 and 80 years of age) with GH deficiency, protein synthesis increases in almost all the cells of the body, coupled with the favored mobilization of fatty acids in Adipose tissue, which increases the amount of in blood and its use as an energy source. It also decreases the amount of glucose used throughout the body resulting in an increase of lean body mass."

Carlos Tapia, Medical Manager at High Specialty Business Unit at Merck Serono in Mexico, said that the administration of such therapy has been shown to improve overall physical strength and sense of wellbeing, which translates in improved quality of life but the specialists are the ones who must evaluate each case personally.

"The use of recombinant human growth hormone should be measured and monitored by specialists in endocrinology, who must perform a comprehensive evaluation to determine whether the clinical characteristics of the person correspond to the clinical data for growth hormone deficiency and then consider if the adult has a healthy diet, physical activity habits and appropriate life style, "he said.

add to favorites email to friend print save as pdf

Related Stories

Growth hormone increases bone formation in obese women

Nov 29, 2011

In a new study presented today at the annual meeting of the Radiological Society of North America (RSNA), growth hormone replacement for six months was found to increase bone formation in abdominally obese women.

Recommended for you

Biomedical team creates 'nerve on a chip'

Dec 24, 2014

Michael J. Moore and J. Lowry Curley first met in the laboratory as professor and student. Now the two Tulane University researchers have started a new biomedical company that's winning praise and awards.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.